Gavin Newsom Speeds Psychedelic Research With New Law Backed by Veterans
California Governor Gavin Newsom has signed Assembly Bill 1103, a measure to accelerate the study of psychedelics.
Read More
Introducing the Ketamine Industry’s Most Comprehensive Professional Liability Coverage
Most ketamine clinics think their liability insurance their ketamine treatments -- but for most it doesn't. We solved this problem.
Read More
September 2025 Roundup: What Ketamine Treatment Costs Across the United States
This September 2025 roundup examines the latest ketamine therapy pricing data from social media platforms, forums, and clinic websites.
Read More
Beyond Traditional Training: How Psychedelics Are Reshaping Executive Leadership
Dr. Catriona Wallace reveals that 52% of surveyed leaders noted long-term improvements in company leadership attributed to psychedelic use.
Read More
IV Ketamine Shows Superior Results Over Nasal Esketamine for Treatment Resistant Depression
A new study shows that IV ketamine delivers more effective relief with treatment resistant depression compared to its nasal counterpart
Read More
Partner Spotlight: How Ketamine Lead Gen – Your Growth Partner in Digital Marketing, Patient Acquisition, and Clinic Success
If you’ve ever felt like your clinic is the best-kept secret in town, you’re not alone. That’s exactly why Ketamine Lead Gen exists.
Read More
Norway Approves Public Funding for Ketamine Depression Treatment
Norway has become the first country to provide national public funding for generic ketamine in treating treatment resistant depression.
Read More
5 Biggest Ketamine Clinic Professional Insurance Misconceptions
Insurance is one of the most misunderstood aspects of running a ketamine clinic. And wrong assumptions can expose clinics to significant risk.
Read More
“Don’t Die” Biohacker Bryan Johnson Considers Ketamine as Latest Anti-Aging Tool
Bryan Johnson, who transforms his body into an anti-aging science experiment, is now considering ketamine therapy.
Read More
Psychedelic Therapy Market Surges Toward $10 Billion Future
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion by 2032.
Read More